Acute cardiopulmonary toxicity of inhaled aldehydes: role of TRPA1

Annals of the New York Academy of Sciences

Volumn 1374, Issue 1, 2016, Pages 59-67

  Conklin, Daniel J ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

acrolein; cardiac dysfunction; irritant receptors; pulmonary injury

Indexed keywords

ACROLEIN; ALDEHYDE; CHEMICAL WARFARE AGENT; TOBACCO SMOKE; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1;

ACUTE TOXICITY; AIR POLLUTION; BREATHING; CARDIOTOXICITY; COMBUSTION; COUGHING; ENVIRONMENTAL EXPOSURE; EVOKED RESPONSE; EXPOSURE; HUMAN; INFLAMMATION; INHALATION; LUNG INJURY; LUNG TOXICITY; MORBIDITY; MORTALITY; NONHUMAN; PAIN; PATHOPHYSIOLOGY; REVIEW; VASODILATATION;

EID: 84983489118     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/nyas.13055     Document Type: Review

References (93)

1. Bessac, B.F. & S.E. Jordt. 2008. Breathtaking TRP channels: TRPA1 and TRPV1 in airway chemosensation and reflex control. Physiology (Bethesda) 23: 360–370.
2. Geppetti, P. et al. 2010. Cough: the emerging role of the TRPA1 channel. Lung 188(Suppl. 1): S63–S68.
3. Ha, M.A. et al. 2015. Menthol attenuates respiratory irritation and elevates blood cotinine in cigarette smoke exposed mice. PLoS One 10: e0117128.
4. Alarie, Y. 1966. Irritating properties of airborne materials to the upper respiratory tract. Arch. Environ. Health 13: 433–449.
5. Ghilarducci, D.P. & R.S. Tjeerdema. 1995. Fate and effects of acrolein. Rev. Environ. Contam. Toxicol. 144: 95–146.
6. Stevens, J.F. & C.S. Maier. 2008. Acrolein: sources, metabolism, and biomolecular interactions relevant to human health and disease. Mol. Nutr. Food Res. 52: 7–25.
7. Anderson, M.M. et al. 1997. Human neutrophils employ the myeloperoxidase–hydrogen peroxide–chloride system to convert hydroxy-amino acids into glycolaldehyde, 2-hydroxypropanal, and acrolein. A mechanism for the generation of highly reactive alpha-hydroxy and alpha,beta-unsaturated aldehydes by phagocytes at sites of inflammation. J. Clin. Invest. 99: 424–432.
8. Dong, J.Z. & S.C. Moldoveanu. 2004. Gas chromatography–mass spectrometry of carbonyl compounds in cigarette mainstream smoke after derivatization with 2,4-dinitrophenylhydrazine. J. Chromatogr. A 1027: 25–35.
9. U.S.E.P.A. 2008. Reregistration eligibility decision (RED) document for acrolein. Series: Prevention, Pesticides and Toxic Substances (7508P). 1–63.
10. Kales, S.N. et al. 2007. Emergency duties and deaths from heart disease among firefighters in the United States. N. Engl. J. Med. 356: 1207–1215.
11. Kales, S.N. et al. 2003. Firefighters and on-duty deaths from coronary heart disease: a case control study. Environ. Health 2: 14.
12. Albin, T.B. 1962. “Handling and toxicology.” In Acrolein. C.W. Smith, Ed.: 234–239. New York: John Wiley and Sons, Inc.
13. Beauchamp, R.O., Jr. et al. 1985. A critical review of the literature on acrolein toxicity. Crit. Rev. Toxicol. 14: 309–380.
14. Leikauf, G.D. et al. 2011. Haplotype association mapping of acute lung injury in mice implicates activin a receptor, type 1. Am. J. Respir. Crit. Care Med. 183: 1499–1509.
15. Fujioka, K. & T. Shibamoto. 2006. Determination of toxic carbonyl compounds in cigarette smoke. Environ. Toxicol. 21: 47–54.
16. Uchiyama, S., Y. Inaba & N. Kunugita. 2010. Determination of acrolein and other carbonyls in cigarette smoke using coupled silica cartridges impregnated with hydroquinone and 2,4-dinitrophenylhydrazine. J. Chromatogr. A 1217: 4383–4388.
17. Carmella, S.G. et al. 2007. Quantitation of acrolein-derived (3-hydroxypropyl)mercapturic acid in human urine by liquid chromatography–atmospheric pressure chemical ionization tandem mass spectrometry: effects of cigarette smoking. Chem. Res. Toxicol. 20: 986–990.
18. DeJarnett, N. et al. 2014. Acrolein exposure is associated with increased cardiovascular disease risk. J. Am. Heart Assoc. 3. doi: 10.1161/JAHA.114.000934.
19. Carmella, S.G. et al. 2009. Effects of smoking cessation on eight urinary tobacco carcinogen and toxicant biomarkers. Chem. Res. Toxicol. 22: 734–741.
20. Destaillats, H., R.S. Spaulding & M.J. Charles. 2002. Ambient air measurement of acrolein and other carbonyls at the Oakland–San Francisco bay bridge toll plaza. Environ. Sci. Technol. 36: 2227–2235.
21. Conklin, D.J. et al. 2011. “Aldehydes and cardiovascular disease.” In Environmental Cardiology: Pollution and Heart Disease. Vol. 8. A. Bhatnagar, Ed.: 390. London: Royal Society of Chemistry.
22. Alarie, Y. 1973. Sensory irritation by airborne chemicals. CRC Crit. Rev. Toxicol. 2: 299–363.
23. Kane, L.E. & Y. Alarie. 1979. Interactions of sulfur dioxide and acrolein as sensory irritants. Toxicol. Appl. Pharmacol. 48: 305–315.
24. Kane, L.E., C.S. Barrow & Y. Alarie. 1979. A short-term test to predict acceptable levels of exposure to airborne sensory irritants. Am. Ind. Hyg. Assoc. J. 40: 207–229.
25. Lee, B.P., R.F. Morton & L.Y. Lee. 1992. Acute effects of acrolein on breathing: role of vagal bronchopulmonary afferents. J. Appl. Physiol. 72: 1050–1056.
26. Symanowicz, P.T., G. Gianutsos & J.B. Morris. 2004. Lack of role for the vanilloid receptor in response to several inspired irritant air pollutants in the C57Bl/6J mouse. Neurosci. Lett. 362: 150–153.
27. Polverino, M. et al. 2012. Anatomy and neuro-pathophysiology of the cough reflex arc. Multidiscip. Respir. Med. 7: 5.
28. Trevisani, M. et al. 2007. 4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1. Proc. Natl. Acad. Sci. U.S.A. 104: 13519–13524.
29. Macpherson, L.J. et al. 2007. Noxious compounds activate TRPA1 ion channels through covalent modification of cysteines. Nature 445: 541–545.
30. Andrade, E.L., F.C. Meotti & J.B. Calixto. 2012. TRPA1 antagonists as potential analgesic drugs. Pharmacol. Ther. 133: 189–204.
31. Andre, E. et al. 2008. Cigarette smoke-induced neurogenic inflammation is mediated by α,β-unsaturated aldehydes and the TRPA1 receptor in rodents. J. Clin. Invest. 118: 2574–2582.
32. Bautista, D.M. et al. 2006. TRPA1 mediates the inflammatory actions of environmental irritants and proalgesic agents. Cell 124: 1269–1282.
33. Simon, S.A. & W. Liedtke. 2008. How irritating: the role of TRPA1 in sensing cigarette smoke and aerogenic oxidants in the airways. J. Clin. Invest. 118: 2383–2386.
34. Engel, M.A. et al. 2011. TRPA1 and substance P mediate colitis in mice. Gastroenterology 141: 1346–1358.
35. + channels. Circ. Res. 104: 987–994.
36. Corley, R.A. et al. 2015. Comparative risks of aldehyde constituents in cigarette smoke using transient computational fluid dynamics/physiologically based pharmacokinetic models of the rat and human respiratory tracts. Toxicol. Sci. 146: 65–88.
37. Vorhees, D.J., W. Herger-Bernays & M.D. McClean. 1997. Human health risk associated with cigarette smoke: the link between smoke constituents and additives. Menzie, Cura & Associates, Chelmsford, MA. http://legacy.library.ucsf.edu/tid/flv91d00/pdf?search=%22566942292%22.
38. Haussmann, H.J. 2012. Use of hazard indices for a theoretical evaluation of cigarette smoke composition. Chem. Res. Toxicol. 25: 794–810.
39. Roux, E. et al. 2002. In vitro effect of air pollutants on human bronchi. Cell Biol. Toxicol. 18: 289–299.
40. Roux, E. et al. 1996. Human and rat airway smooth muscle responsiveness after ozone exposure in vitro. Am. J. Physiol. 271: L631–L636.
41. Hyvelin, J.M. et al. 2000. Cellular mechanisms of acrolein-induced alteration in calcium signaling in airway smooth muscle. Toxicol. Appl. Pharmacol. 164: 176–183.
42. Roux, E. et al. 1998. Calcium signaling in airway smooth muscle cells is altered by in vitro exposure to the aldehyde acrolein. Am. J. Respir. Cell Mol. Biol. 19: 437–444.
43. Ben Jebria, A. et al. 1995. Acrolein-induced smooth muscle hyperresponsiveness and eicosanoid release in excised ferret tracheae. Toxicol. Appl. Pharmacol. 135: 35–44.
44. Ben Jebria, A. et al. 1994. Human bronchial smooth muscle responsiveness after in vitro exposure to acrolein. Am. J. Respir. Crit. Care Med. 149: 382–386.
45. Facchinetti, F. et al. 2007. α,β-Unsaturated aldehydes in cigarette smoke release inflammatory mediators from human macrophages. Am. J. Respir. Cell Mol. Biol. 37: 617–623.
46. Jakab, G.J. 1993. The toxicologic interactions resulting from inhalation of carbon black and acrolein on pulmonary antibacterial and antiviral defenses. Toxicol. Appl. Pharmacol. 121: 167–175.
47. Astry, C.L. & G.J. Jakab. 1983. The effects of acrolein exposure on pulmonary antibacterial defenses. Toxicol. Appl. Pharmacol. 67: 49–54.
48. Valacchi, G. et al. 2005. Inhibition of NFκB activation and IL-8 expression in human bronchial epithelial cells by acrolein. Antioxid. Redox Signal. 7: 25–31.
49. Lambert, C. et al. 2007. Acrolein inhibits cytokine gene expression by alkylating cysteine and arginine residues in the NF-κB1 DNA binding domain. J. Biol. Chem. 282: 19666–19675.
50. Jakab, G.J. 1977. Adverse effect of a cigarette smoke component, acrolein, on pulmonary antibacterial defenses and on viral–bacterial interactions in the lung. Am. Rev. Respir. Dis. 115: 33–38.
51. Borchers, M.T. et al. 2009. The role of T cells in the regulation of acrolein-induced pulmonary inflammation and epithelial-cell pathology. Res. Rep. Health Eff. Inst. 5–29.
52. Lambert, C. et al. 2005. Acrolein in cigarette smoke inhibits T-cell responses. J. Allergy Clin. Immunol. 116: 916–922.
53. Li, L. & A. Holian. 1998. Acrolein: a respiratory toxin that suppresses pulmonary host defense. Rev. Environ. Health 13: 99–108.
54. Li, L. et al. 1997. Acrolein-induced cell death in human alveolar macrophages. Toxicol. Appl. Pharmacol. 145: 331–339.
55. Borchers, M.T. et al. 1999. Monocyte inflammation augments acrolein-induced Muc5ac expression in mouse lung. Am. J. Physiol. 277: L489–L497.
56. Deshmukh, H.S. et al. 2005. Metalloproteinases mediate mucin 5AC expression by epidermal growth factor receptor activation. Am. J. Respir. Crit. Care Med. 171: 305–314.
57. Deshmukh, H.S. et al. 2009. Matrix metalloproteinase-14 mediates a phenotypic shift in the airways to increase mucin production. Am. J. Respir. Crit. Care Med. 180: 834–845.
58. Kajekar, R., P.K. Moore & S.D. Brain. 1995. Essential role for nitric oxide in neurogenic inflammation in rat cutaneous microcirculation. Evidence for an endothelium-independent mechanism. Circ. Res. 76: 441–447.
59. Pozsgai, G. et al. 2010. Evidence for the pathophysiological relevance of TRPA1 receptors in the cardiovascular system in vivo. Cardiovasc. Res. 87: 760–768.
60. Perez, C.M. et al. 2015. Acrolein inhalation alters arterial blood gases and triggers carotid body-mediated cardiovascular responses in hypertensive rats. Inhal. Toxicol. 27: 54–63.
61. Hazari, M.S. et al. 2014. A single exposure to acrolein desensitizes baroreflex responsiveness and increases cardiac arrhythmias in normotensive and hypertensive rats. Cardiovasc. Toxicol. 14: 52–63.
62. Sithu, S.D. et al. 2010. Exposure to acrolein by inhalation causes platelet activation. Toxicol. Appl. Pharmacol. 248: 100–110.
63. Thompson, L.C. et al. 2016. Acrolein inhalation alters myocardial synchrony and performance at and below exposure concentrations that cause ventilatory responses. Cardiovasc. Toxicol. DOI: 10.1007/s12012-016-9360-4.
64. + cells in mice. Arterioscler. Thromb. Vasc. Biol. 31: 1598–1606.
65. Soteriades, E.S. et al. 2005. Obesity and cardiovascular disease risk factors in firefighters: a prospective cohort study. Obes. Res. 13: 1756–1763.
66. Soteriades, E.S. et al. 2011. Cardiovascular disease in US firefighters: a systematic review. Cardiol. Rev. 19: 202–215.
67. Perez, C.M. et al. 2013. Hypoxia stress test reveals exaggerated cardiovascular effects in hypertensive rats after exposure to the air pollutant acrolein. Toxicol. Sci. 132: 467–477.
68. Hazari, M.S. et al. 2011. TRPA1 and sympathetic activation contribute to increased risk of triggered cardiac arrhythmias in hypertensive rats exposed to diesel exhaust. Environ. Health Perspect. 119: 951–957.
69. Bessac, B.F. et al. 2009. Transient receptor potential ankyrin 1 antagonists block the noxious effects of toxic industrial isocyanates and tear gases. FASEB J. 23: 1102–1114.
70. Celermajer, D.S. et al. 1996. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N. Engl. J. Med. 334: 150–154.
71. Celermajer, D.S. et al. 1993. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 88: 2149–2155.
72. Quillen, J.E. et al. 1993. Acute effect of cigarette smoking on the coronary circulation: constriction of epicardial and resistance vessels. J. Am. Coll. Cardiol. 22: 642–647.
73. Raij, L., E.G. DeMaster & E.A. Jaimes. 2001. Cigarette smoke-induced endothelium dysfunction: role of superoxide anion. J. Hypertens. 19: 891–897.
74. Ota, Y. et al. 1997. Impairment of endothelium-dependent relaxation of rabbit aortas by cigarette smoke extract—role of free radicals and attenuation by captopril. Atherosclerosis 131: 195–202.
75. Conklin, D.J. et al. 2009. Glutathione-S-transferase P protects against endothelial dysfunction induced by exposure to tobacco smoke. Am. J. Physiol. Heart Circ. Physiol. 296: H1586–H1597.
76. Awe, S.O. et al. 2006. Acrolein induces vasodilatation of rodent mesenteric bed via an EDHF-dependent mechanism. Toxicol. Appl. Pharmacol. 217: 266–276.
77. Conklin, D.J. et al. 2006. Acrolein generation stimulates hypercontraction in isolated human blood vessels. Toxicol. Appl. Pharmacol. 217: 277–288.
78. Yanaga, A. et al. 2006. Cinnamaldehyde induces endothelium-dependent and -independent vasorelaxant action on isolated rat aorta. Biol. Pharm. Bull. 29: 2415–2418.
79. Romero, F.J. et al. 1997. 4-Hydroxynonenal-induced relaxation of human mesenteric arteries. Free Radic. Biol. Med. 23: 521–523.
80. 2S–NO crosstalk activating a HNO–TRPA1–CGRP signalling pathway. Br. J. Pharmacol. 173: 431–445.
81. Aubdool, A.A. et al. 2014. TRPA1 is essential for the vascular response to environmental cold exposure. Nat. Commun. 5: 5732.
82. Trevisan, G. et al. 2014. TRPA1 receptor stimulation by hydrogen peroxide is critical to trigger hyperalgesia and inflammation in a model of acute gout. Free Radic. Biol. Med. 72: 200–209.
83. Conklin, D., R. Prough & A. Bhatanagar. 2007. Aldehyde metabolism in the cardiovascular system. Mol. Biosyst. 3: 136–150.
84. Bessac, B.F. et al. 2008. TRPA1 is a major oxidant sensor in murine airway sensory neurons. J. Clin. Invest. 118: 1899–1910.
85. Hazari, M.S. et al. 2008. Potentiation of pulmonary reflex response to capsaicin 24 h following whole-body acrolein exposure is mediated by TRPV1. Respir. Physiol. Neurobiol. 160: 160–171.
86. Facer, P. et al. 2000. Do nerve growth factor-related mechanisms contribute to loss of cutaneous nociception in leprosy? Pain 85: 231–238.
87. Koivisto, A. et al. 2012. Inhibiting TRPA1 ion channel reduces loss of cutaneous nerve fiber function in diabetic animals: sustained activation of the TRPA1 channel contributes to the pathogenesis of peripheral diabetic neuropathy. Pharmacol. Res. 65: 149–158.
88. Andersson, D.A. et al. 2013. Methylglyoxal evokes pain by stimulating TRPA1. PLoS One 8: e77986.
89. Wei, H. et al. 2009. Attenuation of mechanical hypersensitivity by an antagonist of the TRPA1 ion channel in diabetic animals. Anesthesiology 111: 147–154.
90. Schwartz, E.S. et al. 2011. Synergistic role of TRPV1 and TRPA1 in pancreatic pain and inflammation. Gastroenterology 140: 1283–1291.e1–e2.
91. Patil, M.J. et al. 2013. Sex-dependent roles of prolactin and prolactin receptor in postoperative pain and hyperalgesia in mice. Neuroscience 253: 132–141.
92. Patil, M.J. et al. 2013. Prolactin regulates TRPV1, TRPA1, and TRPM8 in sensory neurons in a sex-dependent manner: contribution of prolactin receptor to inflammatory pain. Am. J. Physiol. Endocrinol. Metab. 305: E1154–E1164.
93. Conklin, D.J. et al. 2015. Glutathione S-transferase P protects against cyclophosphamide-induced cardiotoxicity in mice. Toxicol. Appl. Pharmacol. 285: 136–148.